These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24439568)
21. Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France). Heeke S; Benzaquen J; Hofman V; Ilié M; Allegra M; Long-Mira E; Lassalle S; Tanga V; Salacroup C; Bonnetaud C; Fayada J; Gazoppi L; Ribeyre L; Castelnau O; Garnier G; Cattet F; Nanni I; de Fraipont F; Cohen C; Berthet JP; Leroy S; Poudenx M; Marquette CH; Denis MG; Barlesi F; Hofman P Clin Lung Cancer; 2020 Jan; 21(1):56-65.e8. PubMed ID: 31519454 [TBL] [Abstract][Full Text] [Related]
22. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer. O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958 [TBL] [Abstract][Full Text] [Related]
23. Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients. Xu S; Jiang J; Yu X; Sheng D; Zhu T; Jin M Lung Cancer; 2014 Mar; 83(3):341-6. PubMed ID: 24485957 [TBL] [Abstract][Full Text] [Related]
24. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing. Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527 [TBL] [Abstract][Full Text] [Related]
25. Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients. Pasquale R; Fenizia F; Esposito Abate R; Sacco A; Esposito C; Forgione L; Rachiglio AM; Bevilacqua S; Montanino A; Franco R; Rocco G; Botti G; Denis MG; Morabito A; De Luca A; Normanno N Pharmacogenomics; 2015; 16(10):1135-48. PubMed ID: 26249748 [TBL] [Abstract][Full Text] [Related]
26. Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer. Sharma A; Zhang G; Aslam S; Yu K; Chee M; Palma JF Mol Diagn Ther; 2016 Jun; 20(3):231-40. PubMed ID: 26984642 [TBL] [Abstract][Full Text] [Related]
27. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction. Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341 [TBL] [Abstract][Full Text] [Related]
28. Clinical influence of switching companion diagnostic tests for EGFR-TKs from Therascreen to Cobas v2. Uchibori K; Takano N; Manabe R; Tsugitomi R; Ogusu S; Tozuka T; Sakamoto H; Yoshida H; Amino Y; Ariyasu R; Kitazono S; Yanagitani N; Nishio M Thorac Cancer; 2021 Mar; 12(6):906-913. PubMed ID: 33528892 [TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Endo K; Konishi A; Sasaki H; Takada M; Tanaka H; Okumura M; Kawahara M; Sugiura H; Kuwabara Y; Fukai I; Matsumura A; Yano M; Kobayashi Y; Mizuno K; Haneda H; Suzuki E; Iuchi K; Fujii Y Lung Cancer; 2005 Dec; 50(3):375-84. PubMed ID: 16199108 [TBL] [Abstract][Full Text] [Related]
30. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085 [TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients. Roengvoraphoj M; Tsongalis GJ; Dragnev KH; Rigas JR Cancer Treat Rev; 2013 Dec; 39(8):839-50. PubMed ID: 23768755 [TBL] [Abstract][Full Text] [Related]
32. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry. Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121 [TBL] [Abstract][Full Text] [Related]
33. [Determination of EGFR gene somatic mutations in tissues and plasma of patients with advanced non-small cell lung cancer]. Brovkina OI; Gordiev MG; Toropovskiy AN; Khodyrev DS; Enikeev RF; Gusev OA; Shigapova LH; Nikitin AG Biomed Khim; 2016 Nov; 62(6):638-644. PubMed ID: 28026806 [TBL] [Abstract][Full Text] [Related]
34. Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study. Kogo M; Fujimoto D; Hosoya K; Nagata K; Nakagawa A; Tachikawa R; Yamashita D; Kitamura Y; Imai Y; Tomii K BMC Cancer; 2020 Feb; 20(1):104. PubMed ID: 32028905 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769 [TBL] [Abstract][Full Text] [Related]
36. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097 [TBL] [Abstract][Full Text] [Related]
37. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Yu J; Kane S; Wu J; Benedettini E; Li D; Reeves C; Innocenti G; Wetzel R; Crosby K; Becker A; Ferrante M; Cheung WC; Hong X; Chirieac LR; Sholl LM; Haack H; Smith BL; Polakiewicz RD; Tan Y; Gu TL; Loda M; Zhou X; Comb MJ Clin Cancer Res; 2009 May; 15(9):3023-8. PubMed ID: 19366827 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples. Hlinkova K; Babal P; Berzinec P; Majer I; Mikle-Barathova Z; Piackova B; Ilencikova D Diagn Mol Pathol; 2013 Jun; 22(2):70-5. PubMed ID: 23628817 [TBL] [Abstract][Full Text] [Related]
39. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer. Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744 [TBL] [Abstract][Full Text] [Related]
40. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. Yatabe Y; Kerr KM; Utomo A; Rajadurai P; Tran VK; Du X; Chou TY; Enriquez ML; Lee GK; Iqbal J; Shuangshoti S; Chung JH; Hagiwara K; Liang Z; Normanno N; Park K; Toyooka S; Tsai CM; Waring P; Zhang L; McCormack R; Ratcliffe M; Itoh Y; Sugeno M; Mok T J Thorac Oncol; 2015 Mar; 10(3):438-45. PubMed ID: 25376513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]